Molecular mechanisms in liver ischemic-reperfusion injury and ischemic preconditioning;Mecanismos moleculares en el daño por isquemia-reperfusión hepática y en el preacondicionamiento isquémico

Revista Medica de Chile

Volumn 133, Issue 4, 2005, Pages 469-476

  Romanque U, Pamela ^a,b,c   Uribe M, Mario ^a   Videla, Luis A ^b  

^a HOSPITAL DEL SALVADOR   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Ischemia reperfusion injury; Liver transplantation; Shock, surgical

Indexed keywords

NITRIC ACID; REACTIVE OXYGEN METABOLITE;

GENE EXPRESSION; GENETICS; HUMAN; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; METABOLISM; METHODOLOGY; MICROCIRCULATION; OXIDATIVE STRESS; PATHOLOGY; REPERFUSION INJURY; REVIEW; VASCULARIZATION;

GENE EXPRESSION; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; MICROCIRCULATION; NITRIC ACID; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 31144435081     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. TEOH N, DELA PENA A, FARELL G. Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase, and cell cycle entry. Hepatology 2002; 36: 94-102.
2. RAMÍREZ P, MARÍN JM, PIÑERO A, CHÁVEZ-CARTAYA R, PARRILLA P. Investigación experimental aplicada a la clínica: isquemia-reperfusión hepática. Cir Esp 2000; 67: 281-91.
3. JAESCHKE H. Molecular mechanism of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-G26.
4. COLLARD CD, LEKOWSKI R, JORDAN JE, AGAH A, STAHL GL. Complement activation following oxidative stress. Mol Immunol 1999; 36: 941-8.
5. CUTRÍN JC, PERRELLI MG, CAVALIERI B, PERALTA C, ROSELLÓ-CATAFAU J, POLI G. Microvascular disfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radical Biol Med 2002; 33: 1200-8.
6. LICHTMAN SN, LEMASTERS JJ. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Sem Liver Dis 1999; 19: 171-204.
7. NAUTA RJ, TSIMOYIANNIS E, URIBE M, WALSH DB, MILLER D, BUTTERFIELD A. The role of calcium ions and calcium channel entry blockers in experimental ischemia-reperfusion-induced liver injury. Ann Surg 1991; 213: 137-42.
8. VIDELA L, FERNÁNDEZ V. Biochemical aspects of cellular oxidative stress. Arch Biol Med Exp 1988; 21: 85-92.
9. NAUTA R, TSIMOYIANNIS E, URIBE M, WALSH D, MILLER D, BUTTERFIELD A. Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obst 1990; 171: 120-5.
10. MARUBAYASHI S, KIYOHIKO D, OCHI K, KAWASAKI T. Role of free radicals in ischemic rat liver cell injury: Prevention of damage by α-tocopherol administration. Surgery 1986; 99: 184-91.
11. NORDSTRÖM G, SEEMAN T, HASSELGREN P. Beneficial effect of allopurinol in liver ischemia. Surgery 1985; 97: 679-83.
12. YOUNES M, STRUBELT O. The involvement of reactive oxygen species in hypoxic injury to rat liver. Res Comm Chem Pathol Pharmacol 1988; 59: 369-81.
13. MCCORD JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Federation Proc 1987; 46: 2402-6.
14. TSUKAMOTO H. Redox regulation of cytokine expression in Kupffer cells. Antioxidants and Redox Signaling 2002; 4: 741-8.
15. PRETTO JR EA. Reperfusion injury of the liver. Transplantation Proc 1991; 23: 1912-4.
16. LEMASTERS JJ, JI S, THURMAN RG. Centrilobular injury following hypoxia in isolated perfused rat liver. Science 1981; 213: 661-3.
17. KNOWLES RG, MONCADA S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-58.
18. IGNARRO LJ. Physiology and pathophysiology of nitric oxide. Kidney Internat 1996; 55 (Suppl): S2-S5.
19. CLEMENS MG. Nitric oxide in liver injury. Hepatology 1999; 30: 1-5.
20. YAMAGUCHI Y, OKABE K, MATSUMURA F, AKISUKI E, MATSUDA T, OHSHIRO H ET AL. Peroxynitrite formation during hepatic allograft rejection. Hepatology 1999; 29: 777-84.
21. BATTISTA S, MENGOZZI G, BAR F, CERUTTI E, POLLET C, TORCHIO ET AL. Nitric oxide level profile in human liver transplantation. Digestive Dis Sci 2002; 47: 528-34.
22. VIDELA LA, FERNÁNDEZ V, CARRIÓN Y, AZZALIS LA, BAINY ACD, JUNQUEIRA VBC. Biochemical mechanism in hepatotoxicity: oxidative stress induced by xenobiotics and hormonal changes. J Braz Assoc Adv Sci 1995; 47: 385-94.
23. BAUERLE PA, BALTIMORE D. NF-κB: ten years after. Cell 1996; 87: 13-20.
24. TAPIA G, FERNÁNDEZ V, VARELA P, GUERRERO J, VIDELA LA. Thyroid hormone-induced oxidative stress triggers nuclear factor-κB activation and cytokine gene expression in rat liver. Free Rad Biol Med 2003; 35: 257-65.
25. TAKAHASHI Y, GANSTER RW, GAMBOTTO A, SHAO L, KAIZU T, WU T ET AL. Role of NF-κB on liver cold ischemia-reperfusion injury. Am J Gastrointest Liver Physiol 2002; 283: G1175-G1184.
26. ALLEN RG, TRESINI M. Oxidative stress and gene regulation. Free Radical Biol Medi 2000; 28: 463-99.
27. PERALTA C, PRATS N, XAUS C, GELPÍ E, ROSELLÓ-CATAFAU J. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30: 1481-9.
28. CLAVIEN PA, YADAV S, SINDRAM D, BENTLEY RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surgery 2000; 232: 155-62.
29. TOTSUKA E, FUNG JJ, URAKAMI A, MORAS N, ISHII T, TAKAHASHI K ET AL. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology 2000; 31: 577-80.
30. BOLLI R. The late phase of preconditioning. Circulation Res 2000; 87: 972-83.
31. PERALTA C, FERNÁNDEZ L, PANES J, PRATS N, SANS M, PIQUE JM ET AL. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-13.
32. TEOH N, LECLERCQ I, DELA PENA A, FARELL G. Low-dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003; 37: 118-28.
33. CARINI R, ALBANO E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480-91.
34. PERALTA C, HOTTER G, CLOSA D, GELPÍ E, BULBENA O, ROSELLÓ-CATAFAU J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 1997; 35: 934-7.
35. 2 receptors. Hepatology 1999; 29: 126-32.
36. DE NADAI C, SESTILI P, CANTONI O, LIÈVREMONT J, SCIORATI C, BARSACCHI R ET AL. Nitric oxide inhibits tumor necrosis-α-induced apoptosis by reducing the generation of ceramide. Proc Natl Acad Sci (USA) 2000; 97: 5480-5.
37. MANNA SK, ZHANG HJ, YAN T, OBERLEY LW, AGARWAL BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J Biol Chem 1998; 273: 13245-54.
38. RAMADORI G, CHRIST B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999; 19: 141-55.
39. BERNELLI-ZAZZERA A, CAIRO G, SCHIAFFONATI L, TACCHINI L. Stress proteins and reperfusion stress in the liver. Ann NY Acad Sci 1992; 21: 120-4.
40. BAUER M, BAUER I. Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxidants Redox Sign 2002; 4: 749-67.
41. SHEN XD, KE B, ZHAI Y, AMERSI F, GAO F, ANSELMO DM ET AL. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation 2002; 74: 315-9.
42. BLYDT-HANSEN TD, KATORI M, LASSMAN C, KE B, COITO AJ, IYER S ET AL. Gene transfer-induced local Heme Oxygenase 1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1-13.
43. MARTINDALE JL, HOLBROOK NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192: 1-15.
44. DUFOUR JF, REDAELLI C. Survival pathways and preconditioning in liver transplantation. Transplant Immunol 2002; 9: 281-93.